The secondary endpoints include achievement of 20% weight reduction, relative change in body weight, change in waist circumference, change in HbA1c, change in systolic blood pressure, change in the quality of life (IWQOL-Lite-CT), and change in short-form physical functioning score (SF-36v2)
The goal isnt rapid or dramatic weight loss its the everyday health benefits that GLP-1 therapy supports: reduced food noise, better digestion, lower inflammation, and improved metabolic health
Furthermore, CME decreased JNK and p38 phosphorylation in LPS-treated cells while leaving ERK unchanged
If losing the most weight is the goal, semaglutide is the clear winner
Since the values obtained by these equations are the amount of total glutathione in treated sample solutions, further calculations are necessary if the actual concentration of glutathione in cells or tissues needs to be determined